It is a pharma private limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2016.
2016 | Vishakhapatnam, Andhra Pradesh, India | ActiveYenovus Pharma Private Limited, a active private limited company, was established on 23 May 2016 in Vishakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290AP2016PTC103314. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹4.96 Cr.
It upholds a compliant status. Its leadership includes Bala Vivek (Director), Balasubramanyam Sangeetha (Director). Past directors included Bala Vivek, Balasubramanyam Sangeetha, Velayutharaja Balasubramanyam. It holds no open charges and ₹19.56 Cr settled loans. Its latest AGM occurred on 28 December 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No: 22H, Sy.No. 34P And 35P, Apsez, Lalam Koduru Village, Rambilli Mandal, Vishakhapatnam, Andhra Pradesh, 531011.
U24290AP2016PTC103314
103314
23 May 2016
₹10.00 Cr
₹4.96 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Yenovus Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bala Vivek | Director | 23 May 2016 | Current |
| Balasubramanyam Sangeetha | Director | 09 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 31 Mar 2021 | Past |
| Pramod Abcsdd | Director | 31 Mar 2021 | Past |
| Pramod Abcsdd | Director | 08 Jan 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Yenovus Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 208.05% increase. The company also saw a substantial fall in profitability, with a 85.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 280.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Yenovus Pharma had a promoter holding of 97.98% and a public holding of 2.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹195,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jan 2022 | Others | ₹1.70 Cr | Satisfied |
| 05 Mar 2018 | Others | ₹17.86 Cr | Satisfied |
Explore comprehensive loan charge details -
Yenovus Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Yenovus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yenovus Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Yenovus Pharma Private Limited last Annual general meeting of members was held on 28 Dec 2024 as per latest MCA records. was documented.
Progress on Balasubramanyam Sangeetha was appointed as a Director was appointed as a Director on 09 Dec 2024 & has been associated with this company since 11 months 29 days . was documented.
Progress on Yenovus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was documented.
The activity A charge registered on 21 Jan 2022 via Charge ID 100540881 with Others was fully satisfied on 08 Sep 2022. was completed.
The activity A charge registered on 05 Mar 2018 via Charge ID 100161351 with Others was fully satisfied on 08 Sep 2022. was completed.
Progress on A charge with Others amounted to Rs. 1.70 Cr with Charge ID 100540881 was registered on 21 Jan 2022. was documented.
The CIN of Yenovus Pharma Private Limited is U24290AP2016PTC103314.
Yenovus Pharma Private Limited is headquartered at Plot No: 22H, Sy.No. 34P And 35P, Apsez, Lalam Koduru Village, Rambilli Mandal, Vishakhapatnam, Andhra Pradesh, 531011.
Yenovus Pharma Private Limited was incorporated on 23 May 2016.
The current directors of Yenovus Pharma Private Limited are
The primary industry of Yenovus Pharma Private Limited is Manufacturing.
Yenovus Pharma Private Limited is unlisted.
The authorized capital of Yenovus Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹4.96 Cr.
The compliance status of Yenovus Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX